Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Prnjavorac, A. Cauševic, S. Semiz, T. Dujic, M. Malenica, E. Mujaric, T. Bego (Tešanj, Sarajevo, Zenica, Bosnia And Herzegovina). Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma. Eur Respir J 2011; 38: Suppl. 55, 478

Member's Comments

No comment yet.

Related content which might interest you: COPD, asthma and C-reactive protein Source: Eur Respir J 2006; 27: 874-876 Year: 2006 The importance of C-reactive protein in patients with acute exacerbation of severe COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 C-reactive protein and childhood asthma Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD Source: Eur Respir J 2015; 45: 76-86 Year: 2015 Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 High sensitivity C-reactive protein in asthma Source: Eur Respir J 2006; 27: 908-912 Year: 2006 High sensitive C-reactive protein in asthmatic patients Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Serum high sensitivity C-reactive protein can distinguish cough-variant and bronchial asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Evaluation of high-sensitivity C-reactive protein in acute asthma Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Procalcitonin and C-reactive protein levels in infective attacks of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003 Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Elevated serum ECP in wheezing infants predicts the development of atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002